Financhill
Back

Roivant Sciences Quote, Financials, Valuation and Earnings

My #1 Coin is...

All the details are on the next page.
Buy
57

ROIV
Roivant Sciences

Last Price:
11.13
Seasonality Move:
12.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Roivant Sciences Price Quote

$11.13

Roivant Sciences Key Stats

Buy
57
Roivant Sciences (ROIV) is a Buy

Day range:
$11.12 - $11.48
52-week range:
$8.25 - $13.24
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
70.35
P/B ratio:
1.47%

Volume:
2.6M
Avg. volume:
5.9M
1-year change:
20.59%
Market cap:
$9B
Revenue:
$61.3M
EPS:
$5.2

How Much Does Roivant Sciences Make?

Is Roivant Sciences Growing As A Company?

  • What Is Roivant Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.18%
  • What Is Roivant Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Roivant Sciences Stock Price Performance

  • Did Roivant Sciences Stock Go Up Last Month?
    Roivant Sciences share price went down by -0.63% last month
  • Did ROIV's Share Price Rise Over The Last Year?
    ROIV share price rose by 20.59% over the past 1 year

What Is Roivant Sciences 52-Week High & Low?

Roivant Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Roivant Sciences?

  • How Much Debt Does Roivant Sciences Have?
    Total long term debt quarterly is $449M
  • How Much Cash Does Roivant Sciences Have?
    Cash and short term investments quarterly total is $6.7B
  • What Is Roivant Sciences’s Book Value Per Share?
    Book value per share is 7.57

Is Roivant Sciences Cash Flow Positive?

  • What Is ROIV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$835.9M
  • What Is Roivant Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $662.3M
  • What Is Roivant Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $5.3B

Roivant Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    ROIV return on invested capital is 154.81%
  • What Is Roivant Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is 138.65%
  • What Is ROIV Return On Equity?
    ROE is a measure of profitability and is 181.87%

Roivant Sciences Earnings Date & Stock Price

Roivant Sciences Competitors

  • Who Are Roivant Sciences's Competitors?
    Below is a list of companies who compete with Roivant Sciences or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals Plc (BDRX)
    • NuCana PLC (NCNA)
    • Verona Pharma PLC (VRNA)

Roivant Sciences Dividend Yield

Data Unavailable

Roivant Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 22.34%
Revenue: 117.8% 24.53%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 16.11
Upside from Last Price: 44.75%

Major Shareholders

  • How many ROIV shares are owned by institutional investors?
    672.4M ROIV shares are owned by institutional investors
  • How many ROIV shares are owned by insiders?
    69.7M ROIV shares are owned by insiders